A conversation on Health Canada s Health Product Advertising Oversight
|
|
- Alexandrina Robinson
- 5 years ago
- Views:
Transcription
1 A conversation on Health Canada s Health Product Advertising Oversight Pharmaceutical Advertising Advisory Board (PAAB) Workshop Toronto November 17, 2016 Alain Musende, PhD Manager, Regulatory Advertising Section Health Canada
2 Purpose To carry out a conversation on Health Canada s oversight on health product advertising. To discuss the relationship between Health Canada and the Pharmaceutical Advertising Advisory Board (PAAB). To provide an update related to health product advertising initiatives. The Distinction Between Advertising and Other Activities Medical devices advertised to the general public Posting of Advertising Complaints 2
3 Why Health Canada Regulates Health Product Advertising To protect the health and safety of Canadians Mandated by law 3
4 Current Regulatory Requirements for Advertising Section 2 Food and Drugs Act: Advertisement includes any representation by any means whatever for the purpose of promoting directly or indirectly the sale or disposal of any food, drug, cosmetic or device. Note: Health Canada uses the policy The Distinction Between Advertising and Other Activities to distinguish promotional campaigns from information. 4
5 Key Regulatory Requirements for Advertising Section 2 Food and Drugs Act: Advertisement includes any representation by any means whatever for the purpose of promoting directly or indirectly the sale or disposal of any food, drug, cosmetic or device. Section C Food and Drug Regulations: No person shall sell or advertise a drug unless it has received a notice of compliance. Section 9(1) Food and Drugs Act: No person shall label, package, treat, process, sell or advertise any drug in a manner that is false, misleading or deceptive or is likely to create an erroneous impression regarding its character, value, quantity, composition, merit or safety. 5
6 Regulatory Provisions for Advertising Clarified Enforced 6
7 How Do We Regulate Health Product Advertising L union fait la force! 7
8 Dynamic Interactions Applicable Federal Statutes: -Food & Drugs Act and Regulations -Controlled Drugs and Substances Act Health Canada Guidance Documents PAAB Code Health Product Advertising Industry Association Codes PAAB Healthcare Professionals / General Public Industry Associations 8
9 Health Canada s Role National regulatory authority for health product advertising. Sets the parameters under which health products are marketed in Canada (e.g. Product Monograph). Puts in place regulations to effectively regulate marketed health products. Provides guidelines for the interpretation of the regulations. 9
10 Health Products and Food Branch s Role Intervenes when advertising: Contravenes regulatory requirements and poses a significant risk to health. Preclearance agencies are unable to obtain willful compliance. Relates to incidents of illegal promotion (i.e., prescription drug advertising to the general public beyond name, price, and quantity, advertising of unauthorized products, off-label promotion, etc.). Contraventions of the legislation and regulations and violations of advertising guidelines are subject to compliance verification. Appropriate compliance & enforcement actions are taken when required (risk-based approach). 10
11 Marketed Health Products Directorate s Roles Responsible for overseeing the regulatory activities of health product advertising. Point of contact with the PAAB. Coordinates requests for clarifications from various stakeholders. Conducts regulatory assessments of certain types of advertising complaints. Ex-officio representative on PAAB Board. Chair of a Branch-wide Advertising Working Group. 11
12 Preclearance of Health Product Advertising The preclearance of advertising of marketed health products is: Governed by a self-regulatory and voluntary system Recommended by some industry associations to their members Strongly recommended by Health Canada The PAAB reviews and preclears health product advertisements to verify compliance with the legislative and regulatory advertising provisions and the PAAB Code of Advertising Acceptance. 12
13 Preclearance of Health Product Advertising (continued) The PAAB verifies that advertising is accurate, balanced and evidence-based The PAAB also offer an independent mechanism to resolve complaints and provides the first route of adjudication of complaints for authorized health products. 13
14 Health Canada and the PAAB You are in good hands with the PAAB! 14
15 Regulatory Provisions for Advertising Clarified Enforced 15
16 PAAB s impact! Section 9(1) Food and Drugs Act: No person shall label, package, treat, process, sell or advertise any drug in a manner that is false, misleading or deceptive or is likely to create an erroneous impression regarding its character, value, quantity, composition, merit or safety. 16
17 Health Canada and the PAAB Health Canada and the PAAB work in close collaboration: Health Canada provides policy clarifications to the PAAB when requested Health Canada resolves complaints referred by the PAAB Health Canada holds an annual bilateral meeting to share information on topics of mutual interest Health Canada is an ex-officio member on the administrative board of the PAAB and attends PAAB s Annual General Meeting Health Canada has the opportunity to comment and provide insight on PAAB s initiatives and code revisions Health Canada maintains ongoing collaboration on educational sessions (workshops) and on guidance document development 17
18 Health Canada and the PAAB (continued) Heath Canada and industry associations support & encourage PAAB s work: Innovative Medicines Canada s Code of Ethical Practices clarifies that members agree to comply with all applicable provisions of Health Canada regulations and the PAAB Code of Advertising Acceptance. A breach of the PAAB Code may be deemed to be a breach of IMC s Code. Complete information about the roles of HC and the PAAB is available in the Guidance Document entitled Health Canada and Advertising Preclearance Agencies Roles Related to Health Product Advertising ( 18
19 The Distinction Between Advertising and Other Activities The purpose is to distinguish material that is deemed promotional from activities that are not. The purpose, content and context must be taken into consideration. If Health Canada determines that the primary purpose of a message is advertising, an assessment is then made regarding compliance with applicable regulations. Dissemination of factual information in various media is not subject to the federal legislative & regulatory advertising provisions. 19
20 The Distinction Between Advertising and Other Activities Although no planned revision until , HC is considering updating the policy to potentially: Expand scope to: o All types of health products including vaccines, medical devices and veterinary drugs o All types of audiences (general public, healthcare professionals, etc.) 20
21 The Distinction Between Advertising and Other Activities Address activities such as: o o o o Social media platforms and other online interactive communications / activities: guidance provided at a 2009 social media PAAB sponsored workshop and which was included in the PAAB Code section 6.5: Static content, dynamic content, user-generated comments, monitoring, linking, search engine techniques, banner ads, apps, QR codes, etc. Patient Web sites for products with risk management plans Link between Consumer Brochures vs Help-Seeking Announcements (Disease Awareness Campaigns) Sales representatives conduct / activities / materials 21
22 The Distinction Between Advertising and Other Activities Update current sections such as: o o o o Institutional Messages / Corporate Web sites Patient materials (eg. access to patient Web sites) Press Releases / Press Kits Continuing Medical Education / Conferences 22
23 Medical Device Advertising Guidelines Lack of Medical Device Advertising Guidance Section 9(1) Food and Drugs Act: No person shall label, package, treat, process, sell or advertise any drug in a manner that is false, misleading or deceptive or is likely to create an erroneous impression regarding its character, value, quantity, composition, merit or safety. Section 20(1) Food and Drugs Act: No person shall label, package, treat, process, sell or advertise any device in a manner that is false, misleading or deceptive or is likely to create an erroneous impression regarding its design, construction, performance, intended use, quantity, character, value, composition, merit or safety.
24 Consumer Advertising of Medical Devices Current consultation: Inclusion of medical device advertising guidance in the Consumer Advertising Guidelines (CAG) for Marketed Health Products. Content will relate to lack of fair balance, exaggeration of merits, omission of safety information, promotion of off-label use, etc. Content will focus on medical devices advertised for sale to and purchased by the general public. The medical device content will not include the advertising of medical procedures involving the use of medical devices by healthcare professionals (e.g. laser eye surgery equipment, laser hair removal equipment, liposuction device, etc.). 24
25 Posting of Health Product Advertising Complaints In July 2015, HC started posting tables of health product advertising complaints that Health Canada has received and addressed, or is currently assessing for next steps. It is a quarterly posting which contributes to the Department s Openness and Transparency Initiative. It provides Canadians with relevant information on advertising complaints that were received by the Department. Complements current practices of Canadian Advertising Preclearance Agencies (APAs) and key international regulatory partners. 25
26 Advertising Prohibitions on Cannabis On November 25, 2014, Health Canada issued an Information Bulletin on advertising prohibitions on cannabis ( The publishing of promotional materials and advertisements are of serious concern. Health Canada is especially concerned about advertisements of any kind which are false, misleading or deceptive, and those which advertise cannabis in relation to particular therapeutic claims. Licensed producers must refrain from giving the impression that they, their products, or their activities are endorsed by Health Canada. If a licensed producer is found to be in contravention of the advertising prohibitions in the F&DA, they could be subject to prosecution, and if convicted would be liable to fines ranging from $250,000 to $5,000,000, or to a term of imprisonment ranging from six months to two years, or to both (s.31.2 FDA). For individuals seeking information about the new Access to Cannabis for Medical Purposes Regulations, contact Health Canada. Call toll-free at or omc-bcm@hc-sc.gc.ca. 26
27 Conclusion The PAAB is a key contributor to Health Canada s mandate of protecting the health and safety of Canadians Health Canada strives to maintain an efficient relationship with the PAAB, involving a close collaboration and a transparent & ongoing communication. Health Canada and the PAAB have implemented measures in place to stay informed on advertising trends and issues. Health Canada assists the PAAB in achieving their mandate. 27
28 Contact Alain Musende, PhD Manager, Regulatory Advertising Section Marketed Health Products Directorate Health Products and Food Branch Tel.: (613) Facsimile: (613) Regulatory Advertising Section Tel.: (613) Facsimile: (613) Web site Health Canada s Regulatory Requirements for Advertising: 28
29 29
PAAB Workshop. Health Canada s Regulatory Advertising Oversight Key Recent Initiatives
PAAB Workshop Health Canada s Regulatory Advertising Oversight Key Recent Initiatives November 20 & 22, 2018 Alain Musende, PhD Manager, Section for Transparency and Advertising Regulatory Surveillance
More informationPAAB Workshop. Advertising Jurisdiction Lead & Key Trend Advertising of Biosimilars. November 15, 2017
PAAB Workshop Advertising Jurisdiction Lead & Key Trend Advertising of Biosimilars November 15, 2017 Alain Musende, PhD Manager, Therapeutic Effectiveness & Policy Bureau Health Canada Purpose: To discuss:
More informationThe PAAB Code and Canadian Laws Prohibiting Deceptive Advertising of Healthcare Products
The PAAB Code and Canadian Laws Prohibiting Deceptive Advertising of Healthcare Products Presentation to the PAAB s Annual Training Workshops November 24, 2015, Montreal November 26, 2015, Toronto by Bill
More informationRECORD OF DISCUSSIONS
RECORD OF DISCUSSIONS CANADIAN ADVERTISING PRECLEARANCE AGENCIES and HEALTH CANADA Health Protection Building, 200 Tunney s Pasture Driveway, Ottawa, Room 0218 Tuesday April 13, 2016 10:00 a.m. 12:30 p.m.
More informationAdvertising, APS categories and target audiences. Dannie Newman Reviewer
Advertising, APS categories and target audiences Dannie Newman Reviewer dannien@paab.ca www.paab.ca Agenda Advertising vs non-advertising PAAB APS Categories Advertising with Product Claims Editorial HCP
More informationPublic Attestation Criteria for Consumer Advertising Preclearance Agencies Recommended by Health Canada
December 8, 2006 Health Canada s Recommended Public Attestation Criteria for Advertising Preclearance Agencies in Canada who provide review and preclearance services of nonprescription drugs and natural
More informationHealth Products and Food Branch Inspectorate
Our Mandate: To promote good nutrition and informed use of drugs, food, medical devices and natural health products, and to maximize the safety and efficacy of drugs, food, natural health products, medical
More informationOPDP Update on Oversight of Prescription Drug Promotion
OPDP Update on Oversight of Prescription Drug Promotion Thomas Abrams Director Office of Prescription Drug Promotion Food and Drug Administration November 3, 2014 1 Topics Policy and Guidance Development
More informationMerck s Alignment with PhRMA DTC Principles (Updated January 30, 2009)
Merck s Alignment with PhRMA DTC Principles (Updated January 30, 2009) Effective January 1, 2006, the Pharmaceutical Research Manufacturer s Association (PhRMA) implemented the PhRMA Guiding Principles
More informationGuidelines for Social Media Engagement. for the Consumer Health Product Industry VOLUNTARY GUIDE
Guidelines for Social Media Engagement for the Consumer Health Product Industry VOLUNTARY GUIDE March 2016 Table of Contents 1.0 Background. 3 1.1 Objective.. 3 1.2 Guiding Principles.. 4 2.0 Scope.. 4
More informationAdvertising Standards Authority. Natural Health Products New Zealand Compliance Workshop 29 th May 2018
Advertising Standards Authority Natural Health Products New Zealand Compliance Workshop 29 th May 2018 Advertising Standards Authority Tripartite process - Advertisers / Agencies / Media Front of house
More informationThe Distinction Between Advertising and Other Activities
POLICY Issued: January 12, 1996 Health Products and Food Branch Administrative Update: August 2005 The Distinction Between Advertising and Other Activities Issue Health Canada recognizes the importance
More informationMEDICAL COUNCIL OF NEW ZEALAND
MEDICAL COUNCIL OF NEW ZEALAND NOVEMBER 16 www.mcnz.org.nz Statement on advertising Introduction 1. The Medical Council believes that clear and accurate information about the services provided by doctors
More informationPhRMA GUIDING PRINCIPLES DIRECT TO CONSUMER ADVERTISEMENTS ABOUT PRESCRIPTION MEDICINES
PhRMA GUIDING PRINCIPLES DIRECT TO CONSUMER ADVERTISEMENTS ABOUT PRESCRIPTION MEDICINES P hrma GUIDING PRINCIPLES DIRECT TO CONSUMER ADVERTISEMENTS ABOUT PRESCRIPTION MEDICINES PREAMBLE Given the progress
More informationLegislative and Regulatory Modernization for Therapeutic Products
Legislative and Regulatory Modernization for Therapeutic Products Maurica Maher Associate Director, Office of Legislative and Regulatory Modernization, Health Products and Food Branch, Health Canada Presented
More informationThe Medicines Act 1981 provides the following relevant definitions.
GUIDELINE 1 Medical Devices Checklist for Advertising Medical Devices to Consumers and to Healthcare Professionals Last Updated August 2016 What kind of product is this guideline for? What is the purpose
More informationmasterclass for branded
Digital marketing masterclass for branded materials Speaker: Dannie Newman, Reviewer, PAAB Agenda Understand how target audience and product schedules intersect to determine the regulations relevant to
More informationInitial Draft Discussion Document for A Canadian Orphan Drug Regulatory Framework
Initial Draft Discussion Document for A Canadian Orphan Drug Regulatory Framework Table of Contents Preamble... 3 Background... 3 What is a rare disease?... 3 What is an orphan drug?... 3 Unique Challenges
More informationJapan. Chapter 16. Nishimura & Asahi. 1 General Medicinal Products
Chapter 16 Somuku Iimura Nishimura & Asahi Yoko Kasai 1 General Medicinal Products 1.1 What laws and codes of practice govern the advertising of medicinal products in your jurisdiction? In, the Act on
More informationCanada: Consumer Protection Law Overview
Canada: Consumer Protection Law Overview Stikeman Elliott LLP Canada: Consumer Protection Law Overview Overview... 2 Federal Consumer Protection Laws... 2 Regulation of Products Sold in Canada... 2 Deceptive
More informationCSL BEHRING COMPLIANCE PLAN
CSL BEHRING COMPLIANCE PLAN I. POLICY AND PURPOSE Statement of Values CSL Behring adheres to a policy of strict compliance with the laws and regulations governing its business, not only as a legal obligation,
More informationFDA Update on Compounding
FDA Update on Compounding Julie Dohm, JD, PhD Senior Science Advisor for Compounding, Center for Drug Evaluation and Research; Agency Lead on Compounding, FDA Compounding A Snapshot Compounded drugs: Are
More informationReport of the Signatory Companies: Volume XII
2016 Introduction The Pharmaceutical Research and Manufacturers of America s (PhRMA) Guiding Principles on Direct-to-Consumer (DTC) Advertisements about Prescription Medicines ( PhRMA Guiding Principles
More informationAAD ADVERTISING STANDARDS
Approved: Board of Directors 11/14/09 AAD ADVERTISING STANDARDS The American Academy of Dermatology and AAD Association (collectively, the Academy ) seeks to advance the science and art of dermatology
More informationINTERNATIONAL SECURITIES ASSOCIATION FOR INSTITUTIONAL TRADE COMMUNICATION ANTITRUST COMPLIANCE POLICY
INTERNATIONAL SECURITIES ASSOCIATION FOR INSTITUTIONAL TRADE COMMUNICATION 1.0 Antitrust Compliance Policy ANTITRUST COMPLIANCE POLICY The policy of the International Securities Association for Institutional
More informationPublishers Advertising Playbook Misleading and Deceptive conduct
Publishers Advertising Playbook Misleading and Deceptive conduct Tips and tricks to keep retailers out of trouble. Penalties Whether an advertisement appears in print or on a digital platform it must comply
More informationGUIDANCE ABOUT CLAUSE 3
GUIDANCE ABOUT CLAUSE 3 On occasion pharmaceutical companies will have a legitimate need to tell health professionals and others about unlicensed medicines or indications. This guidance will help companies
More informationDRUGS DIRECTORATE GUIDELINES PREPARATION OF DRUG IDENTIFICATION NUMBER SUBMISSIONS
DRUGS DIRECTORATE GUIDELINES PREPARATION OF DRUG IDENTIFICATION NUMBER SUBMISSIONS Health Protection Branch Health Canada Table of Contents Introduction.... 1 Section I Change in Manufacturer's Name and/or
More informationPromoting Medical Products Globally
Promoting Medical Products Globally Handbook of Pharma and MedTech Compliance INDONESIA This publication is copyright. Apart from any fair dealing for the purpose of private study or research permitted
More informationThe 2018 Therapeutic Goods Advertising Code & associated guidance
Complementary Medicines Australia submission to the Therapeutic Goods Administration Consultation: The 2018 Therapeutic Goods Advertising Code & associated guidance April 2018 To: Advertising Consultation
More informationJuly 11, Notice. Our file number:
July 11, 2018 Notice Our file number: 18 107850 551 Release of the Therapeutic Products Directorate Statistical Report 2017/2018 for the Patented Medicines (Notice of Compliance) Regulations and Data Protection
More informationCanada's National Model Construction Codes Development System
CONSTRUCTION Canada's National Model Construction Codes Development System Introduction Canadian Commission on Building and Fire Codes Canada has one of the best standards of construction in the world
More informationGuide to North America Healthcare Compliance 2016/2017
Guide to North America Healthcare Compliance 2016/2017 Dr. Reddy s Laboratories, Inc. NOTICE: this information is provided pursuant to the requirements of California Health & Safety Code 119400, 119402,
More informationAmendments to DSA s Code of Practice 2018
Changes to the new Code are highlighted in blue Wording Direct sellers are bound by the Code to the extent that complying with it is a condition of their role in distributing members products. In supplying
More informationHealth Canada Enforcement of Consumer Products
September 27, 2016 Vietnam Buyers Training Health Canada Enforcement of Consumer Products Jerry Wu Regional Manager, Consumer Product Safety Health Canada OVERVIEW Monitoring the Marketplace Inspections
More informationReview of the Code of Ethics of the Australian Association of National Advertisers
Review of the Code of Ethics of the Australian Association of National Advertisers Submission from the Queen Victoria Women s Centre Trust 24 September 2010 Overview The Queen Victoria Women s Centre Trust
More informationAdvisory Services. New CPA Code: A Preview of the Changes. Introduction. Development of the CPA Code
Advisory Services New CPA Code: A Preview of the Changes This is part of a series of guidance prepared to explain the impact of the new CPA Code of Professional Conduct ( CPA Code ) that came into effect
More informationRegulation of Cell and Gene Therapy Products in Canada
Regulation of Cell and Gene Therapy Products in Canada Canadian Blood and Bone Marrow Transplant Group June 8, 2018 Nadine Kolas, PhD Senior Policy Analyst Blood, Cells, Tissues and Organs Biologics and
More informationNOTICE. Re: Guidance Document GD211: Guidance on the Content of Quality Management System audit reports
June 8, 2011 NOTICE Our file number: 11-110913-528 Re: Quality Management System audit reports is pleased to announce the release of the guidance document GD211: Guidance on the Content of. A draft version
More informationNatural and Non-prescription Health Products Priorities & Updates Health and Beauty Conference CHP Canada and CCTFA September 19, 2014
Helping the people of Canada maintain and improve their health Aider les Canadiens et les Canadiennes à maintenir et à améliorer leur état de santé Natural and Non-prescription Health Products Priorities
More informatione of ethics code of ethics code of ethics code s code of ethics code of ethics code of ethics
e of ethics code of ethics code of ethics code thics WFDSA code of ethics Code code of of ethics Ethics code of eth e of ethics code of ethics code of ethics code s code of ethics code of ethics code of
More informationCanada's National Model Construction Codes Development System
Canada's National Model Construction Codes Development System 1.0 Introduction 1.1 Canadian Commission on Building and Fire Codes Canada has one of the best standards of construction in the world and a
More informationHealth Canada s NHP Vigilance Activities
Health Canada s NHP Vigilance Activities Canadian Health Food Association (CHFA) East October 3, 2013 Scott Sawler Director General Marketed Health Products Directorate Overview NHP Program & MHPD Activities
More informationAMENDED Draft Report of the Compounding Workgroup
AMENDED Draft Report of the Compounding Workgroup This report summarizes the actions taken by a workgroup convened by the Board of Pharmacy pursuant to the enactment clause of HB 1035 passed during the
More informationPromoting Medical Products Globally
Promoting Medical Products Globally Handbook of Pharma and MedTech Compliance PERU This publication is copyright. Apart from any fair dealing for the purpose of private study or research permitted under
More informationNIUE LAWS LEGISLATION AS AT DECEMBER 2006 ENVIRONMENT BIOSAFETY (GENETICALLY MODIFIED ORGANISMS) REGULATIONS /4 4 July 2006
NIUE LAWS LEGISLATION AS AT DECEMBER 2006 ENVIRONMENT BIOSAFETY (GENETICALLY MODIFIED ORGANISMS) REGULATIONS 2006 1 Short title 2 Interpretation 3 Objectives 4 The precautionary approach 2006/4 4 July
More informationCitizen Engagement in Policy Development and Priority-setting:
Citizen Engagement in Policy Development and Priority-setting: The Health Products and Food Branch Public Advisory Committee Roger Farley, Director General in collaboration with Sylvie Cantin, Director,
More informationGUIDELINES ON IMPLEMENTING PRODUCT PLACEMENT RULES I. GENERAL PROVISIONS. Subject
Pursuant to Article 18, Para 1, Indent 8; Article 20, Para 1, Indent 11, and Article 55 of the Law on Audio and Audiovisual Media Services (Official Gazette of the Republic of Macedonia, nos. 184/13, 13/14,
More informationTriple C Housing, Inc. Compliance Plan
Triple C Housing, Inc. Compliance Plan Adopted by Board of Directors on draft November 13, 2014 Overview Triple C Housing, Inc. is committed to its consumers, employees, contractual providers, vendors,
More informationAmerican Academy of Orthopaedic Surgeons 2010 Annual Meeting
American Academy of Orthopaedic Surgeons 2010 Annual Meeting Off-Label Device Use: When Clinical Need Outpaces Regulatory Approval The Legal Parameters of Off-Label Use March 10, 2010 Kathleen McDermott
More informationPromoting Medical Products Globally
Promoting Medical Products Globally Handbook of Pharma and MedTech Compliance Peru This publication is copyright. Apart from any fair dealing for the purpose of private study or research permitted under
More informationPromoting Medical Products Globally
Promoting Medical Products Globally Handbook of Pharma and MedTech Compliance VENEZUELA This publication is copyright. Apart from any fair dealing for the purpose of private study or research permitted
More informationSUMMER VILLAGE OF VAL QUENTIN BYLAW
SUMMER VILLAGE OF VAL QUENTIN BYLAW 265-18 A BYLAW TO ESTABLISH A CODE OF CONDUCT FOR MEMBERS OF COUNCIL WHEREAS, pursuant to section 146.1(1) of the Municipal Government Act, a council must, by bylaw,
More informationAPPENDIX 1: STATUTORY FRAMEWORK FOR THE REGULATION OF BROADCAST ADVERTISING
APPENDIX 1: STATUTORY FRAMEWORK FOR THE REGULATION OF BROADCAST ADVERTISING Advertising Standards 1 The Communications Act 2003 requires Ofcom to set, and from time to time review and revise, codes containing
More informationThe federal government plans to legalize cannabis for recreational use by July 2018
Regional Solicitor Legal & Court Services Memorandum To: From: Regional Council Joy Hulton, Regional Solicitor Date: May 25, 2017 Re: Legalization and Regulation of Cannabis Background As part of its 2015
More informationWorld Federation of Direct Selling Associations
World Federation of Direct Selling Associations 1667 K Street, NW Suite 1100 Washington, DC 20006 Telephone 202 452 8866 Facsimile 202.452 9010 www.wfdsa.org WFDSA Code of Ethics Preface This Code Contains
More informationThe Emerging Role of Post-Market Evidence Generation in Decision-Making: Linkages to the Product Lifecycle Approach
The Emerging Role of Post-Market Evidence Generation in Decision-Making: Linkages to the Product Lifecycle Approach CADTH Symposium April 6, 2009 Maurica Maher, MD, MSc Associate Director Office of Legislative
More informationPegatron Corporation Corporate Social Responsibility Practice Principles
Pegatron Corporation Corporate Social Responsibility Practice Principles Chapter I General Principles Article 1 In order to fulfill the corporate social responsibility initiatives and to promote economic,
More informationINTRODUCTION. Overview of Compliance Program. I. Leadership and Structure. GSK Ethics & Compliance Program US Operations
GSK Ethics & Compliance Program US Operations INTRODUCTION GlaxoSmithKline (GSK) is one of the world s leading research-based pharmaceutical and healthcare companies. GSK s global mission is to improve
More informationAdvertising and Marketing Genetic Tests New Pathways or Old Roads?
Advertising and Marketing Genetic Tests New Pathways or Old Roads? Kathleen M. Sanzo, Morgan Lewis FDLI Advertising & Promotion Conference Wednesday, September 28, 2016 Context for Use of Genetic Tests
More informationWHO GLOBAL BENCHMARKING TOOL (GBT) FOR EVALUATION OF NATIONAL REGULATORY SYSTEM OF MEDICAL PRODUCTS
WHO GLOBAL BENCHMARKING TOOL (GBT) FOR EVALUATION OF NATIONAL REGULATORY SYSTEM OF MEDICAL PRODUCTS MARKET SURVEILLANCE AND CONTROL (MC): INDICATORS AND FACT SHEETS Revision VI version 1 November 2018
More informationRomania. Raluca Vasilescu Cabinet M Oproiu. Pharmaceutical Trademarks 2015/2016. A Global Guide
Romania Raluca Vasilescu Cabinet M Oproiu Pharmaceutical Trademarks 2015/2016 A Global Guide Romania Cabinet M Oproiu Author Raluca Vasilescu Selection, clearance and registration In Romania, pharmaceutical
More informationTHE REGULATION of advertising to children
The regulation of advertising to children in Australia Peter Le Guay, Cowley Hearne Lawyers Peter Le Guay continues our series of legal briefings in conjunction with the Global Advertising Lawyers Alliance
More informationTHE BROADCAST CODE FOR ADVERTISING TO CHILDREN
THE BROADCAST CODE FOR ADVERTISING TO CHILDREN The Broadcast Code for Advertising to Children (Children s Code) is designed to complement the general principles for ethical advertising outlined in the
More informationGuidelines for the Advertising of Pest Control Products
Regulatory Proposal PRO2015-01 Guidelines for the Advertising of Pest Control Products (publié aussi en français) 26 March 2015 This document is published by the Health Canada Pest Management Regulatory
More informationHealth Canada s Experience on the Use of Nanotechnology in Drug Products
Health Canada s Experience on the Use of Nanotechnology in Drug Products FDA/PQRI Workshop Nanomaterial Drug Products: Current Experience and Management of Potential Risks January 14, 2014 Hripsime Shahbazian,
More informationOverview of the IMPACT Working Group on Legislative and Regulatory Infrastructure
Overview of the IMPACT Working Group on Legislative and Regulatory Infrastructure Medical products are essential to cure diseases and to safe lives. If a medical product cannot achieve this goal because
More informationOverview of the IMPACT Working Group on Legislative and Regulatory Infrastructure
Overview of the IMPACT Working Group on Legislative and Regulatory Infrastructure Medical products are essential to cure diseases and to safe lives. If a medical product cannot achieve this goal because
More informationKansas Pharmacy Act Amendments; Filling and Refilling Prescriptions; Biological Products; Senate Sub. for HB 2055
Kansas Pharmacy Act Amendments; Filling and Refilling Prescriptions; Biological Products; Senate Sub. for HB 2055 (Act). Senate Sub. for HB 2055 makes several amendments to the Kansas Pharmacy Act The
More informationR e s p o n s i b l e C a r e. The safety, health and environmental initiative of the chemical industry
R e s p o n s i b l e C a r e The safety, health and environmental initiative of the chemical industry Our Vision Our Mission Responsible Care envisages a profitable, sustainable chemical sector in South
More informationAAC Regulation No. 1: FALSE, DECEPTIVE AND MISLEADING ADVERTISING
AAC Regulation No. 1: FALSE, DECEPTIVE AND MISLEADING ADVERTISING A. Authority, Purpose and Scope 1. SCR 3.130(7.02)(6) provides in part that the Attorneys Advertising Commission [identified throughout
More informationTERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS 1. Purpose An Audit Committee (hereinafter called the Committee ) of the Board of Directors (hereinafter called the Board ) of the Business
More informationKADMON HOLDINGS, INC. BOARD OF DIRECTORS REGULATORY AND COMPLIANCE COMMITTEE
Purpose KADMON HOLDINGS, INC. BOARD OF DIRECTORS REGULATORY AND COMPLIANCE COMMITTEE Effective as of June 27, 2016 The Regulatory and Compliance Committee (the Committee ) is a committee of the Board of
More informationEMPLOYEE CONDUCT & DISCIPLINE
EMPLOYEE CONDUCT & DISCIPLINE FIT FOR DUTY To clearly define the expectation of Craig regarding the conduct of all employees as it relates to their ability to perform their jobs in an appropriate, effective
More informationLabour Evaluating Occupational Health and Safety Systems Follow-up
Labour Evaluating Occupational Health and Safety Systems Follow-up SUMMARY Virtually all occupational injuries, diseases and fatalities are preventable. The Occupational Health and Safety Act, Regulation
More informationGovernance Policies for PCORnet, the National Patient-Centered Clinical Research Network
Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network 1.0 Leadership and Decision Making When reading this document, it is important to note that there are several categories
More informationDisclosure of Material Connections in Blogs and Other Forms of Consumer-Generated Media
FTC Publishes Final Guides Concerning the Use of Endorsements and Testimonials Prepared for the Council of Public Relations Firms by Davis & Gilbert LLP The Federal Trade Commission (FTC) announced that
More informationCORPORATE COMPLIANCE PROGRAM CODE OF CONDUCT PLEDGE OF PRINCIPLES
CORPORATE COMPLIANCE PROGRAM CODE OF CONDUCT PLEDGE OF PRINCIPLES 2015 1 THE CODE OF CONDUCT Our code of conduct, the Pledge of Principles, was developed to help guide the behavior and performance of employees
More informationEthics in Social Media 2017: Risks of Social Media
Ethics in Social Media 2017: Risks of Social Media March 17, 2017 New York, NY Michele Huresky WW Counsel, HPE Software Services Hewlett Packard Enterprise Kelly Pellicci Attorney Dun & Bradstreet John
More informationContent includes: All rates are excluding GST.
Physiotherapy New Zealand (PNZ) is the national membership organisation for physiotherapists and physiotherapy students. Every year we provide over 3,600 members with advocacy, education, information and
More informationDirect Selling Code of Ethics
2017 Direct Selling Code of Ethics A member of WFDSA World Federation of Direct Selling Associations www.wfdsa.org Table of Contents 4 PREFACE 4 GENERAL Scope Glossary of Terms Companies Direct Sellers
More informationAmendment to the Medical Council s Statement on advertising in relation to the use of testimonials
8 March 2016 Amendment to the Medical Council s Statement on advertising in relation to the use of testimonials The Medical Council of New Zealand (the Council) is proposing to amend part of its Statement
More informationUse of Regulatory Tools
Page 1 of 10 Use of Regulatory Tools 1. Purpose and Scope... 2 2. Application... 2 3. Authority... 2 4. References... 2 5. The Civil Aviation Authority s regulatory tools... 3 6. Identifying appropriate
More informationThird Party Advertising Information Session Municipal Election. April 19 th, toronto.ca/elections 1
Third Party Advertising Information Session 2018 Municipal Election April 19 th, 2018 toronto.ca/elections 1 Introductions Fiona Murray Deputy City Clerk, Election Services 416-392-8019; fiona.murray@toronto.ca
More information2016 Medicare-Medicaid Plan Compliance Plan
2016 Medicare-Medicaid Plan Compliance Plan Document maintained by: Christy K. Bosse Director & Compliance Officer Updated as of: 3/7/2016 1 Compliance Plan Governance The Medicare-Medicaid Plan ( MMP
More informationCANADA (HEALTH CANADA)
1 GMP GAZETTE TM March 2015 HPFBI CANADA (HEALTH CANADA) Notice, Re: Regulatory Decision Summaries and Submissions Under Review Who s affected? Manufacturers of prescription drugs (pharmaceuticals and
More informationHealth Products and Food Branch Inspectorate Graham Spry Building, 2 nd Floor 250 Lanark Avenue Address Locator # 2002B OTTAWA, Ontario K1A 0K9 December 1, 2007 07-117987-250 To: ALL INTERESTED PARTIES
More informationGuidelines of Corporate Governance
Guidelines of Corporate Governance December 2017 The Board of Directors (the Board ) of Radian Group Inc. ( Radian or the Company ) has established guidelines for corporate governance based on an assessment
More informationContents. NRTT Proprietary and Confidential - Reproduction and distribution without prior consent is prohibited. 2
Privacy Policy Contents INTRODUCTION... 4 PROCESSING PRINCIPALS... 5 FAIRNESS AND LAWFULNESS... 5 RESTRICTION TO A SPECIFIC PURPOSE... 5 DELETION... 5 CONFIDENTIALITY AND DATA SECURITY... 5 RELIABILITY
More informationGreen Advertising a Swiss Perspective. IBA Annual Conference Buenos Aires, October 2008 Lukas Bühlmann, LL.M. Zurich
Green Advertising a Swiss Perspective IBA Annual Conference Buenos Aires, October 2008 Lukas Bühlmann, LL.M. Zurich Overview General Principles Unfair Competition Law Specific Legislation Eco-Labels Sanctions
More informationHealth Products and Food Branch Inspectorate
Our Mandate: To manage and deliver a national compliance and enforcement program for blood and donor semen; cells, tissues and organs; drugs (human and veterinary); medical devices and natural health products,
More informationFDA COMMUNICATIONS. Oversight in a. DIGITAL era A WHITE PAPER
FDA COMMUNICATIONS Oversight in a DIGITAL era 2008-2013 A WHITE PAPER Mark S. Senak, J.D. Author, Eye on FDA Senior Vice President & Partner Fleishman-Hillard 04 / 2013 Table of Contents Summary Overview...
More informationAllergan plc COMPREHENSIVE COMPLIANCE PROGRAM
Allergan plc COMPREHENSIVE COMPLIANCE PROGRAM 1. Compliance with Law All colleagues, officers and directors of the Company shall respect and comply with all applicable federal, state, local and foreign
More informationStem Cell Uses and FDA Regulation
Stem cells have been called everything from cure-alls to miracle treatments. But don t believe the hype. Some unscrupulous providers offer stem cell products that are both unapproved and unproven. So beware
More informationAlberta Energy Regulator Mandate and Roles Document
Alberta Energy Regulator Mandate and Roles Document Contents 1.0 Preamble... 3 1.1 Context... 3 2.0 Mandate... 3 2.1 Background and Legislation... 3 2.2 Mandate... 5 2.3 Adjudicative Functions... 5 3.0
More informationRules of Engagement for MSLs - Appropriate Interactions with Internal and External Stakeholders
Rules of Engagement for MSLs - Appropriate Interactions with Internal and External Stakeholders Daniel Snyder, PhD Medical Director, Neurology North America Medical Affairs Ipsen Biopharmaceuticals, Inc.
More informationAdvertising Policy: Journals of the American College of Rheumatology
Advertising Policy: Journals of the American College of Rheumatology Principles Governing Advertising in Journals of the American College of Rheumatology These principles are applied by the American College
More informationSHRINERS HOSPITALS FOR CHILDREN CORPORATE COMPLIANCE PLAN
SHRINERS HOSPITALS FOR CHILDREN CORPORATE COMPLIANCE PLAN 1.0 INTRODUCTION Shriners Hospitals for Children ( SHC ) is committed to conducting itself according to applicable business ethical standards and
More informationCommunications Guidelines - ICF Toronto Chartered Chapter 2015/2016
Communications Guidelines - ICF Toronto Chartered Chapter 2015/2016 The ICF Toronto Charter Chapter communicates with its members and outside groups through various means including a website, events, social
More informationAPPLICATION OF THE KING IV REPORT ON CORPORATE GOVERNANCE FOR SOUTH AFRICA 2016 TM (King IV TM )
(Incorporated in the Republic of South Africa) (Registration number 2006/019240/06) APPLICATION OF THE KING IV REPORT ON CORPORATE GOVERNANCE FOR SOUTH AFRICA 2016 TM (King IV TM ) DATE OF ISSUE: MAY 2018
More information